We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA SHOULD CHANGE TIME LIMITS IN cGMP DRAFT GUIDANCE
FDA SHOULD CHANGE TIME LIMITS IN cGMP DRAFT GUIDANCE
February 20, 2004
The time limitations defined in an FDA draft guidance on dispute resolution would place manufacturers at a disadvantage when using the system or result in dispute resolution requests that are incomplete, according to PhRMA.